Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab
Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab
Active, not recruiting · NCT05363631 · Registry updated 2025-12-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab | Clear-cell metastatic renal cell carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, clear cell renal carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Active, not recruiting | Phase 1 / Phase 2 | 2025-12-10 | NCT05363631 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mohammed Milhem | 3 |
| University of Iowa | 102 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Iowa Hospitals & Clinics | Iowa City | United States | 31 |